Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 562 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Radiographic Examination Clear all

Conditions: Lung Cancer
Interventions: annual screening, bronchoscopic and lung imaging studies, comparison of screening methods, computed tomography, radiography, study of high risk factors; Procedure
Lead sponsor: Jewish Hospital and St. Mary's Healthcare; Other
Eligibility: 40 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Breast Cancer
Interventions: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET); Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Recurrent AL Amyloidosis, Refractory AL Amyloidosis
Interventions: Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Computed Tomography, Dexamethasone, Echocardiography Test, Ixazomib Citrate, Magnetic Resonance Imaging, Positron Emission Tomography, Transabdominal Ultrasound, Venetoclax, X-Ray Imaging; Procedure · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 16
States / cities: Duarte, California • Sacramento, California • Atlanta, Georgia + 10 more

Conditions: Endodontic Disease, Periapical Diseases, Periapical Periodontitis, Root Canal Infection
Interventions: Irrisafe ip, GentleWave System, Waterlase iPlus; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 14 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Breast Cancer
Interventions: FFDM Plus DBT, FFDM Alone; Device
Lead sponsor: Fujifilm Medical Systems USA, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 298 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 5
States / cities: Scottsdale, Arizona • Iowa City, Iowa • Rochester, New York + 2 more

Conditions: Hyperparathyroidism
Interventions: Vitamin D, Four-dimensional computed tomography (4DCT); Drug · Device
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders, Immune System Diseases, Common Variable Immunodeficiency
Interventions: e-ATG, Immunosuppression Only Conditioning, Reduced Intensity Conditioning, GVHD Prophylaxis, Allogeneic HSC, Bisulfan, Prednisone, Cyclophosphamide, MMF, Mesna, Tacrolimus, Pentostatin, PFTs, DEXA, Bone Marrow Aspirate & Biopsy, EKG, 2D ECHO; Drug · Procedure · Diagnostic Test
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 4 Years and older
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2030
U.S. locations: 2
States / cities: Bethesda, Maryland • Minneapolis, Minnesota

Conditions: Gastrointestinal Cancer, Pancreatic Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer
Interventions: Cyclophosphamide, Fludarabine, Aldesleukin, anti-Kirsten rat sarcoma virus (KRAS) Glycine(G) to Aspartic Acid(D) substitution at codon 12 peripheral blood lymphocytes (PBL), EKG, CT, MRI, PET, Chest x-ray, Photography; Drug · Biological · Diagnostic Test + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 72 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cholangiocarcinoma
Interventions: ERCP and Photodynamic Therapy, ERCP only; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Charlotteville, Virginia

Conditions: Missing Teeth
Interventions: dental implant placement and immediate provisionalization; Device
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: 20 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Optic Neuropathy
Interventions: magnetic resonance image (MRI), Optical Coherence Tomography (OCT); Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Pulmonary Function Test, CT Scans, Questionnaires, MRI, Xenon gas; Diagnostic Test · Behavioral · Biological
Lead sponsor: Eric A. Hoffman; Other
Eligibility: 20 Years to 89 Years
Enrollment: 341 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2015
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Mental Disorders
Interventions: Testing (MRS, US, DEXA, blood tests); Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 6 Years to 18 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Diabetes Mellitus, Type 2, Diabetes, Type 2 Diabetes, Pre Diabetes
Interventions: Insulin resistance testing, OGTT, Fat biopsy, DXA scan, MRI, 1H-MRS, Tirzepatide, Pioglitazone; Procedure · Radiation · Drug
Lead sponsor: Stanford University; Other
Eligibility: 30 Years to 70 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Palo Alto, California • Stanford, California

Conditions: Asymptomatic Carotid Stenosis, Symptomatic Carotid Stenosis, TCD, HITS
Interventions: Transcranial Doppler (TCD); Device
Lead sponsor: Ochsner Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Non-Compaction Cardiomyopathy
Interventions: Echocardiography, Magnetic resonance imaging (MRI), Computed tomography (CT); Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 3
States / cities: Palo Alto, California • Cleveland, Ohio • Philadelphia, Pennsylvania

Conditions: Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Interventions: Chest Radiography, Computed Tomography, Follow-Up, Imaging Technique, Questionnaire Administration; Procedure · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pancreatic Cancer
Interventions: Endoscopic Retrograde Cholangiopancreatography, Standard of care; Procedure · Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 19 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: COPD
Interventions: Get Palliative Care: four educational learning module videos; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertension, Renovascular
Interventions: qMT-MRI to detect fibrosis.; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Breast Cancer, Cancer of the Breast
Interventions: Prognosia Breast, Mammogram, MRI; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 25 Years to 55 Years · Female only
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Normal Subjects
Interventions: PET/CT Scan; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 20 Years to 75 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Lumbar Degenerative Disc Disease
Interventions: Radiostereometric Analysis; Radiation
Lead sponsor: OAD Orthopaedics; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Warrenville, Illinois

Conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable Breast Carcinoma, Metastatic Breast Carcinoma
Interventions: Atezolizumab, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan, Computed Tomography, Magnetic Resonance Imaging, Olaparib, Positron Emission Tomography, Questionnaire Administration, X-Ray Imaging; Drug · Procedure · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 58
States / cities: Phoenix, Arizona • Scottsdale, Arizona • La Jolla, California + 43 more

Search by objective public record fields.

Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer

Using Diagnostic Tools to Stage Breast Cancer

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Comparison of Clinical Outcomes Between GentleWave® and Biolase®

A Multi-Reader Multi-Case Pivotal Trial

Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma

Efficacy of a Dental Implant System for Immediate Restoration

Biomechanics of Optic Neuropathy

Image and Model Based Analysis of Lung Disease

Measurement of Cardiometabolic Risk in Antipsychotic-Treated Children

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

Transcranial Doppler(TCD) Evaluation of High Intensity Transient Signals and Carotid Disease

International Consortium for Multimodality Phenotyping in Adults With Non-compaction

Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice

Palliative Care Health Literacy Education and QOL Compared to Usual Care

A Study to Evaluate Renal Fibrosis Using MRI Techniques

Precision Supplemental Imaging in Women With Dense Breasts

A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone

Radiostereometric Analysis of Spine Arthrodesis

Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer